Skip to main content
. 2020 Feb 15;12(2):497. doi: 10.3390/nu12020497

Table 2.

Parameters of glycaemic response in participants classified as having either a monophasic or complex glucose curve shape at control visit and treatments with 50 and 400 mg of Enzogenol®.

Parameters of Glycaemic Response Monophasic Group Complex Group
Control Paired to 50 mg of Enzogenol® 50 mg of Enzogenol® p Control Paired to 400 mg of Enzogenol® 400 mg of Enzogenol® p Control Paired to 50 mg of Enzogenol® 50 mg of Enzogenol® p Control Paired to 400 mg of Enzogenol® 400 mg of Enzogenol® p
n 12 - 11 - 13 - 9 -
Gender (M/F) 3/9 - 3/8 - 7/6 - 5/4 -
Mean glucose iAUC (mmol/L·min) 335.4 ± 34.0 241.3 ± 20.2 0.034 * 353.6 ± 31.5 249.3 ± 25.4 0.012 * 222.7 ± 26.6 238.4 ± 32.7 0.392 233.5 ± 36.4 219.1 ± 19.5 0.614
Mean %PG 44.9 ± 8.3 28.9 ± 3.8 0.083 47.5 ± 8.6 31.4 ± 7.9 0.010 * 43.4 ± 5.9 28.7 ± 8.2 0.012* 47.3 ± 7.2 27.7 ± 5.4 0.025 *
Mean time to glucose peak (min) 35.0 ± 2.8 32.5 ± 2.5 0.504 35.5 ± 3.0 32.7 ± 4.0 0.441 28.8 ± 2.7 28.8 ± 4.0 1.000 28.3 ± 3.0 26.7 ± 4.9 0.729
Mean glucose peak value (mmol/L) 8.8 ± 0.3 8.3 ± 0.4 0.177 8.9 ± 0.3 7.9 ± 0.3 0.025 * 7.7 ± 0.3 8.2 ± 0.4 0.315 7.8 ± 0.3 8.0 ± 0.3 0.531
Mean 2hPG (mmol/L) 6.6 ± 0.2 6.3 ± 0.2 0.171 6.7 ± 0.3 6.1 ± 0.3 0.027 * 6.3 ± 0.2 5.9 ± 0.3 0.149 6.5 ± 0.3 6.1 ± 0.2 0.224

* Significant difference between control and 50 or 400 mg of Enzogenol® within each glucose curve shape group (p < 0.05); Significant difference in control visit values between monophasic and complex glucose curve shape groups at 50 mg of Enzogenol® (p < 0.05); Significant difference in control visit values between monophasic and complex glucose curve shape groups at 400 mg of Enzogenol® (p < 0.05); Abbreviations: iAUC: incremental area under the curve of postprandial glucose; %PG: percentage increment of postprandial glucose; 2hPG: 2h postprandial glucose at 120 min of the oral glucose tolerance test (OGTT).